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The effect of intracoronary diltiazem, EGTA (ethylene- 15% (p < 0.01) by intracoronary EGTA (n = 8). Insignif- 
bis@aminomethylether)-N,N’-tetraacetic acid), nifedi- icant reductions in infarct size were found after treatment 
pine, verapamil and isotonic saline solution as placebo on with intracoronary verapamil (63 f 18%, n = 8) and 
reperfusion injury was investigated in regionally ischemic, intracoronary nifedipine (68 f 9%, n = 7). Regional 
reperfused porcine hearts. The left anterior descending systolic shortening of the risk region, which did not differ 
coronary artery was distally occluded for 45 min and was among the groups before occlusion and during ischemia, 
reperfused for 3 days. Intracoronary infusion was started recovered to the greatest extent in the EGTA-treated pigs 
immediately before reperfusion and continued during 45 (p < 0.01 compared with values in the control group). 
min of reperfusion. Infarct size was determined as the ratio Treatment with intracoronary calcium antagonists resulted 
of infarcted (tetrazolium stain) to ischemic myocardium in only marginal improvement of systolic shortening. Re- 
(dye technique). Regional systolic shortening was assessed perfusion-induced rhythm disturbances were not benefi- 
by sonomicrometry. cially affected by either treatment. 
Apart from left ventricular end-diastolic pressure before 
ischemia and during 45 min of reperfusion, global hemo- 
dynamic values in the five treatment groups did not differ; 
in particular, calculated left ventricular oxygen consump- 
tion before and during ischemia was equally low. Intracor- 
onary EGTA decreased coronary venous free calcium con- 
centration to about 70% of baseline value. Infarct size was 
reduced from 76 + 10% (control group, n = 8) to 60 f 10% 
(p < 0.01) by intracoronary diltiazem (n = 8) and to 55 + 
It is concluded that reperfusion injury exists in region- 
ally ischemic, reperfused porcine hearts, which can be 
attenuated by intracoronary EGTA and intracoronary dil- 
tiazem administered during the first 45 min of reperfusion. 
The favorable action of EGTA is ascribed to a reduced 
ionized extracellular calcium concentration, whereas the 
beneficial mechanism of diltiazem is unknown. 
(J Am Co11 Cardiol1989;13:1395401) 
Early restoration of blood flow represents a potent means to 
reduce infarct size and mortality in patients with acute 
myocardial infarction (1,2). Whether reperfusion of ischemic 
myocardium may cause cell death in myocytes that have 
survived the phase of ischemia is still subject to controversy. 
Treatments aimed at suppressing biochemical reactions that 
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are considered to be involved in the genesis of reperfusior. 
injury in intact animals, e.g., scavenging of oxygen free 
radicals (3-6) or anti-inflammatory agents (7-9), have exhib- 
ited conflicting results. Sudden intracellular uptake of cal- 
cium during reperfusion (lo), which can result in contraction 
band necrosis and mitochondrial accumulation of calcium 
(1 1), appears to be another mechanism for the evolution of 
reperfusion injury. In this study we examined whether 
intracoronary treatment with three calcium channel antago- 
nists administered only during reperfusion, and lowered 
intracoronary free calcium concentration during reperfusion, 
would reduce infarct size and improve regional systolic 
shortening in porcine hearts subjected to 45 min of ischemia 
and 3 days of reperfusion. 
0735-1097/89/$320 
1396 KLEIN ET AL. 
CALCIUM ANTAGONISTS AND CALCIUM IN REPERFUSION INJURY 
Methods 
Medication, anesthesia, general surgical procedures and 
measurement of infarct size have been described in detail in 
previous studies (6,9,12). Fifty male and female farm pigs 
weighing 35 to 48 kg were used in this study. 
General experimental design. After median thoracotomy, 
the left anterior descending coronary artery was dissected 
free at the beginning of its distal third. Left ventricular 
pressure and its first derivative (dP/dt max) were measured 
with a 5F Millar catheter-tipped manometer. Blood pressure 
was assessed in the ascending aorta with a fluid-filled cath- 
eter connected to a Statham transducer. A 5F multipurpose 
catheter was advanced from a jugular vein through the 
coronary sinus into the ostium of the great cardiac vein. A 
4F Rentrop catheter with a 3F tip (USCI) was introduced 
under fluoroscopic control through the right carotid artery 
into the proximal part of the left anterior descending coro- 
nary artery. One pair of ultrasonic crystals (13) was im- 
planted in the subendocardial layer of the planned ischemic 
region oriented parallel to the short axis (14). 
Regional systolic shortening was determined by the ul- 
trasonic transit time method (15,16). Analogue tracings of 
the signals were obtained from direct writing recordings. The 
end-diastolic distance of the crystals was determined at the 
onset of ventricular systole. Relative systolic shortening was 
assessed as the difference of distances between the begin- 
ning of ventricular systole and aortic valve closure over 
end-diastolic distance x 100. Regional systolic shortening 
and global hemodynamic variables, including left ventricular 
peak pressure, left ventricular end-diastolic pressure, dias- 
tolic blood pressure, dP/dt max and heart rate, were re- 
corded before occlusion, at 5 min intervals during ischemia 
and during 45 min of reperfusion and after 3 days of 
reperfusion. Left ventricular oxygen consumption (MVO,) 
was calculated from the hemodynamic data before occlusion 
and during ischemia with use of Bretschneider’s equation 
(17). 
The coronary artery was occluded at the prepared site for 
45 min and was reperfused for 3 days. In this preparation, 
occlusion of the coronary artery at the specified site renders 
about 15 g of the left ventricular muscle (average weight 120 
g) ischemic. Forty-five minutes after the onset of reperfu- 
sion, the chest was closed in layers and the animal was 
allowed to recover. On the third postoperative day, the pig 
was reanesthetized and thoracotomy was repeated. After 
measurement of global hemodynamics and regional systolic 
shortening, the coronary artery was occluded at exactly the 
same site, a central venous injection of 20 ml 10% fluorescein 
sodium solution was administered to label the well perfused 
myocardium with a green fluorescent color and the heart was 
excised. The area at risk of necrosis was determined by 
planimetry of the nonfluorescent myocardium of four heart 
slices with use of enlarged photographs (13 x 18 cm). 
Infarcted myocardium was assessed by incubating the heart 
slices in nitroblue tetrazolium solution (18,19). Infarct size 
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was calculated as a ratio of infarcted myocardium over risk 
region X 100. 
Experimental protocol. Fifty pigs were randomly as- 
signed to one of the four treatment groups or to the control 
group. The intracoronary infusion of the active compounds 
or of isotonic sodium chloride solution as placebo was 
started 60 s before release of the coronary occlusion and was 
continued for 45 min during reperfusion. The four treatment 
groups, each consisting of 10 pigs, received either intracor- 
onary diltiazem (Godecke) (0.25 mglmin for 16 min followed 
by 0.125 mglmin for 30 min), intracoronary nifedipine 
(Bayer) (0.05 mglmin for 16 min followed by 0.025 mglmin 
for 30 min), intracoronary verapamil (Knoll) (0.125 mg/min 
for 16 min followed by 0.062 mglmin for 30 min) or intracor- 
onary EGTA (ethylene-bis-(p-aminomethylether)-N,N’- 
tetraacetic acid; analytical grade; Serva) neutralized to a pH 
value of 7.4 with sodium hydroxide. The dosage of EGTA 
was adjusted according to systolic blood pressure and 
ranged between 20 and 32 pmol/min. In general, the initial 
dose was 28 pmol EGTAlmin, and the concentration was 
reduced when systolic blood pressure decreased to ~70 mm 
Hg. 
Coronary venous blood concentrations of total and free 
calcium were determined with standard laboratory tech- 
niques before occlusion and after 2, 5, 10, 20 and 40 min of 
reperfusion. Arterial calcium concentrations were measured 
before and after 40 min of reperfusion. 
Statistics. All data are presented as mean values t SD. 
Overall statistical comparisons among the groups were per- 
formed with the Kruskal-Wallis H test. When this test 
indicated statistical significance, the results of the different 
groups were analyzed with the Wilcoxon-Mann-Whitney U 
test (20). Results within a group were compared with the 
Wilcoxon test for paired observations. Probability values 
~5% (p < 0.05) were considered statistically significant. 
Results 
During the first postoperative night, premature deaths 
occurred in 10 pigs-2 each in the diltiazem, verapamil and 
control groups, respectively, 3 in the nifedipine group and 1 
in the EGTA group. In the latter group, one pig that 
developed ventricular fibrillation on reperfusion could not be 
resuscitated. Therefore, the results are based on 7 experi- 
ments in the nifedipine group and on 8 in each of the other 
four groups (total 39 pigs). 
Rhythm disturbances. Ventricular fibrillation during isch- 
emia occurred in 15 pigs: 2 in the diltiazem group, 3 each in 
the nifedipine, verapamil and control groups and 4 in the 
EGTA group. In most experiments, reperfusion induced 
various types of tachyarrhythmias, including accelerated 
idioventricular rhythms, premature ventricular complexes, 
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short runs of ventricular tachycardia and ventricular 
fibrillation. Ventricular fibrillation on reperfusion was ob- 
served in three pigs in the EGTA group, two in the ver- 
apamil group and one in the diltiazem group. It did not 
occur in the nifedipine-treated or control groups. Except for 
one pig in the EGTA group, ventricular fibrillation was 
always immediately reversed by direct electrical counter- 
shocks. 
Reperfusion-induced rhythm disturbances were charac- 
terized by a sudden increase in heart rate. Comparison of the 
heart rates measured immediately before and after 1,2,3,4, 
5 and 10 min of reperfusion did not indicate any beneficial 
effect of the four treatments on reperfusion-induced tachy- 
arrhythmias. The mean increases in heart rate were 24% 
(diltiazem group), 73% (EGTA group), 38% (nifedipine 
group), 37% (verapamil group) and 21% (control group). 
Global hemodynamics (Table 1). Significant differences 
among the groups (Kruskal-Wallis test) were observed only 
for left ventricular end-diastolic pressure before occlusion 
and during 45 min of reperfusion. Before occlusion, left 
ventricular end-diastolic pressure was significantly lower in 
the EGTA group than in the nifedipine (p < 0.01) or the 
diltiazem (p < 0.01) group. During 45 min of reperfusion, it 
was significantly higher in the nifedipine-treated pigs than in 
the pigs in the control (p < 0.01) EGTA (p < 0.01) and 
verapamil-treated (p < 0.02) groups. Calculated left ventric- 
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Figure 1. Free coronary venous calcium concentration in the 
EGTA-treated animals before treatment and during 40 min of 
reperfusion. The dosage of intracoronary (i.c.) EGTA (ethylene- 
bis-(/Saminoethylether)-N,N’-tetraacetic acid) is given at the bot- 
tom of the figure. Ca++ = calcium ion; mval = mmol/valence. 
ular oxygen consumption before and during ischemia was 
equally low in all groups. 
Effect of EGTA treatment on free coronary vein calcium 
concentration. Coronary vein calcium concentrations did 
not change significantly in calcium antagonist and control 
experiments during reperfusion. Total arterial and coronary 
vein calcium concentrations that amounted to 4.9 + 0.3 
mval/liter were not significantly affected by intracoronary 
EGTA treatment. Before occlusion, free coronary vein 
calcium concentrations were slightly (0.06 + 0.03 mvallliter) 
but significantly higher than arterial concentrations. Intra- 
coronary EGTA therapy reduced mean free coronary vein 
calcium concentrations to about 70% of baseline values 
(Fig. 1). 
Infarct size. Risk regions of the five groups did not differ. 
The areas at risk of necrosis that were determined on 
photographs measured 980 + 354 mm2 (diltiazem group), 
1,278 + 442 mm2 (EGTA group), 1,218 ? 336 mm2 (nifedi- 
pine group), 1,043 ? 170 mm2 (verapamil group) and 1,184 * 
246 mm2 (control group). Infarct size in the five groups is 
depicted in Figure 2. Treatment with diltiazem and with 
EGTA significantly reduced mean necrosis formation by 
21% (p < 0.01) and 28% (p < O.Ol), respectively. Infarct size 
in these two groups was also significantly smaller compared 
with that in the nifedipine treatment group (p < 0.05). 
Reduction in infarct size by verapamil did not reach statis- 
tical significance, although mean infarct size in this group 
was only 5% larger than that in the group treated with 
diltiazem. 
Recovery of regional systolic shortening. Baseline values 
of the end-diastolic distances of the ultrasonic crystals did 
not differ. These were 10.6 ? 2.8 mm (diltiazem group), 
10.7 2 1.8 mm (EGTA group), 9.8 + 1.7 mm (nifedipine 
I diltiazem Cl EGTA Q nikdipine 
E verapamil ??contml exp. 
Figure 2. Infarct size of the five treatment groups after 45 min of 
ischemia and 3 days of reperfusion; p values are related to the infarct 
size of the control group. Other abbreviations as in Figure 1. 
group), 9.5 + 0.8 mm (verapamil group) and 10.4 2 2.4 mm 
(control group). In all experiments, reperfusion induced a 
pronounced decrease in end-diastolic distance. After 10 min 
of reperfusion, mean end-diastolic distance was reduced to 
75% (diltiazem group), 72% (EGTA group), 79% (nifedipine 
group), 74% (verapamil group) and 69% (control group) 
compared with the values immediately before repet-fusion. 
Regional systolic shortening of the risk region in the five 
groups is shown in Figure 3. No difference among the groups 
was observed before ischemia and before reperfusion. After 
3 days of reperfusion, regional systolic shortening had im- 
proved to the greatest extent in the EGTA-treated pigs (p < 
Figure 3. Regional systolic shortening of the risk region of the five 
groups; p values are related to regional systolic shortening of the 
control group after 3 days of reperfusion (reperf.). Other abbrevia- 
tions as in Figure 1. 
50 r T 
betorr owlusion b&xc rcperf. 3 duys of repcff. 
I diltiozem Q EGTA 0 ni*dipine E vcropomil 
d9 Controls 
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0.01 compared with control). Recovery of regional myocar- 
dial function of the diltiazem-, nifedipine- and verapamil- 
treated animals reached borderline significance. 
Discussion 
Calcium in regionally ischemic, reperfused myocardium. 
Myocardium reversibly injured by 10 min of transient isch- 
emia does not accumulate calcium. However, 40 min of 
regional ischemia followed by reperfusion results in an 
l&fold increase of calcium in the damaged tissue (21), which 
occurs during the early phase of reperfusion (22). Much of 
the intracellular calcium is found in dense bodies within 
mitochondria. The process of mitochondrial uptake of cal- 
cium does not indicate that these organelles have died 
already. On the contrary, intact mitochondria prefer to 
accumulate calcium in preference to phosphorylation of 
adenosine triphosphate (ATP) (23). Mitochondria over- 
loaded with calcium exhibit profound functional deteriora- 
tion. Oxidative phosphorylating activity and ATP-generating 
capacity become considerably impaired (23,24). Whether the 
intracellular uptake of calcium during reperfusion deter- 
mines the transition from reversible to irreversible injury in 
some jeopardized myocytes is still unresolved. Various 
studies (25-27) in globally ischemic heart preparations dem- 
onstrated that functional recovery after transient ischemia 
can be improved by a reduced extracellular calcium concen- 
tration. On the other hand, elevated extracellular calcium 
concentrations abolished functional impairment observed 
after short-term ischemia in regionally ischemic, reperfused 
canine hearts (28). Reperfusion of regionally ischemic canine 
myocardium with calcium-free blood revealed contradictory 
results in regard to ultrastructural cell damage. It was 
reported in one study (29) that this treatment preserved 
morphology after 45 min of transient ischemia, whereas 
another study (30) that used a similar protocol failed to 
demonstrate this beneficial effect. 
The results of the present study support the concept that 
reperfusion injury exists in regionally ischemic hearts. Re- 
duced free coronary calcium concentrations during 45 min of 
reperfusion significantly decreased infarct size and improved 
recovery of regional systolic shortening. Although reduced 
afterload has been found to favorably affect systolic bulging 
during ischemia (31), it is unlikely that the lower left ven- 
tricular peak pressure in the EGTA group accounts for the 
better recovery of regional function after 3 days of reperfu- 
sion. Whether EGTA treatment only accelerated functional 
recovery or whether this therapy induces ultimate improve- 
ment of systolic shortening by reducing infarct size cannot 
be answered with certainty. Because we were unable to 
measure free calcium concentrations in the arterial blood 
that perfused the risk region, we had to rely on blood 
concentrations determined in the corresponding vein. Ex- 
trapolation of coronary vein to coronary artery free calcium 
concentration may result in a small error. Because free 
coronary vein calcium concentrations could not be measured 
on-line, it was impossible to achieve equal reductions of 
ionized calcium by the infusion of EGTA. 
Administration of intracoronary EGTA is not without 
risks. Preliminary experiments had demonstrated that the 
therapeutic range of intracoronary EGTA is rather small. 
The intracoronary infusion of 40 pmol EGTAlmin, which 
decreased free coronary vein calcium concentration to about 
0.6 mvaliliter, induced ventricular tachycardia, and higher 
intracoronary EGTA doses always resulted in ventricular 
fibrillation. The optimal treatment durations and dosages of 
intracoronary EGTA and of intracoronary calcium antago- 
nists during reperfusion are not known. We treated the pigs 
during 45 min of reperfusion because it was demonstrated 
that 20 min of reperfusion was sufficient to reverse uhra- 
structural changes of reversibly injured myocytes (32). 
Calcium antagonists for the treatment of reperfusion in- 
jury. The mechanisms involved in the cellular uptake of 
calcium during reperfusion are not clearly defined. It is 
suggested that calcium enters the myocyte primarily by an 
increased permeability of the sarcolemma to calcium, which 
does not require membrane disruption (33,34). Whether 
calcium may also enter the cells by a sodium-calcium ex- 
change (35,36) or by the voltage-dependent slow calcium 
channel is subject to controversy. Furthermore, the role of a 
fast calcium channel (37.38) for the cellular uptake of cal- 
cium on reperfusion has not yet been studied. In an isolated 
septum preparation, neither verapamil (39) nor nifedipine 
(40) was able to prevent intracellular calcium accumulation 
when the drug was administered during reperfusion. How- 
ever, diltiazem was partially protective in a papillary muscle 
preparation (41) and nifedipine delayed the intracellular 
uptake of calcium in isolated rat hearts (34). 
At leust 37 studies have been performed to test the effect 
of calcium rrntagonists on infarct size in different unimul 
models (reviewed in Rqf. 421. In three of them (43-45), a 
calcium antagonist was administered only during ischemia 
and during reperfusion, which lasted for 3 to 4 h (43.44) or 1 
week (45). Infarcted myocardium was delineated by tetrazo- 
lium staining. In two of the studies (43,44), infarct size was 
insignificantly reduced by either intracoronary verapamil 
(43) or intravenous diltiazem (44). However, a reperfusion 
period of 3 to 4 h, which was used in these studies, may have 
been too short to identify accurately necrotic myocardium 
by a tetrazolium stain when areas of no reflow were present 
(19). In the third study (45). nisoidipine, a derivative of 
nifedipine. was ineffective in treating reperfusion injury in 
baboons. In that study and in the canine study (43) that 
tested verapamil. reperfusion was started only after 3 h of 
ischemia, a time when mitochondrial accumulation of cal- 
cium may no longer occur (11). In the present study, the 
dosages of the calcium antagonists were guided by therapeu- 
tic plasma levels of these compounds in humans (46). The 
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intracoronary infusion of the calcium antagonists warranted 
blood concentrations in the coronary artery that were ~2.5 
to 5-fold higher than usual therapeutic plasma levels, even 
when maximal coronary vasodilation was taken into ac- 
count. 
Comparison of the three calcium antagonists. The reason 
for the different effects of the three calcium antagonists on 
infarct size remains to be elucidated. Although the vasodi- 
lator adenosine administered during reperfusion has reduced 
infarct size and improved functional recovery in canine 
hearts (47), it is unlikely that the results of our study can be 
ascribed to different degrees of vasodilation because nifedi- 
pine is a potent vasodilator (48). The three calcium antago- 
nists produced margjnal improvement in regional systolic 
shortening. Whether this effect can be extrapolated to a 
better ultimate improvement of regional function due to 
infarct size reduction is uncertain because it has been 
demonstrated (49) that verapamil attenuated postischemic 
dysfunction in canine hearts after short-term ischemia when 
no infarctions were present. 
Conclusions. Our study suggests that reperfusion injury 
exists in regionally ischemic porcine hearts and that this 
injury can be attenuated by intracoronary EGTA and intra- 
coronary diltiazem administered during 45 min of reperfu- 
sion. At the given drug dosages, diltiazem was superior to 
nifedipine but only insignificantly better than verapamil. 
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